Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-10-25-Speech-2-267-500"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20111025.25.2-267-500"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
"The European Medicines Agency (EMA) was established by Regulation (EC, Euratom) No 726/2004 of the European Parliament and of the Council, of 31 March 2004, and is covered by the Framework Financial Regulation created by Regulation (EC, Euratom) No 2343/2002 of the Commission, of 19 November 2002. This report, by Mr Stavrakakis, concerns discharge in respect of the implementation of the budget of the EMA for the financial year 2009. On 10 May 2011, Parliament agreed to postpone the decision to grant the Executive Director of the EMA discharge for the financial year 2009, since the report by the Court of Auditors expressed reservations about the legality and regularity of compliance with the Financial Regulation as regards underlying transactions. Given that the Management Board of the EMA sent a letter to the European Parliament on 17 June 2011 on the measures taken to correct the irregularities, and in view of the 10 August 2011 letter from the Executive Director, following the questions raised during the debate on discharge to the EMA for 2009 at the 13 July 2011 meeting of Parliament’s Committee on Budgetary Control, I am voting for the report."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples